Clinical course of hypertrophiccardiomyopathy with survival to advanced age

Maron, 1997, Hypertrophic cardiomyopathy, Lancet, 350, 127, 10.1016/S0140-6736(97)01282-8 Wigle, 1995, Hypertrophic cardiomyopathy. Clinical spectrum and treatment, Circulation, 92, 1680, 10.1161/01.CIR.92.7.1680 Spirito, 1997, The management of hypertrophic cardiomyopathy, N Engl J Med, 336, 775, 10.1056/NEJM199703133361107 Wigle, 1985, Hypertrophic cardiomyopathy, Prog Cardiovasc Dis, 28, 1, 10.1016/0033-0620(85)90024-6 Frank, 1968, Idiopathic hypertrophic subaortic stenosis, Circulation, 37, 759, 10.1161/01.CIR.37.5.759 Shah PM, Adelman AG, Wigle ED, et al. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1973;34 and 335 Suppl 1:III79–95 McKenna, 1984, Hypertrophic cardiomyopathy, Arch Dis Child, 59, 971, 10.1136/adc.59.10.971 Fiddler, 1978, Idiopathic hypertrophic subaortic stenosis in the young, Am J Cardiol, 42, 793, 10.1016/0002-9149(78)90099-1 Shirani, 1993, Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation, Am J Cardiol, 72, 434, 10.1016/0002-9149(93)91136-6 Maki, 1998, Predictors of sudden cardiac death in hypertrophic cardiomyopathy, Am J Cardiol, 82, 774, 10.1016/S0002-9149(98)00455-X Spirito, 2000, Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy, N Engl J Med, 342, 1778, 10.1056/NEJM200006153422403 Elliott, 2000, Sudden death in hypertrophic cardiomyopathy, J Am Coll Cardiol, 36, 2212, 10.1016/S0735-1097(00)01003-2 Hardarson, 1973, Prognosis and mortality of hypertrophic obstructive cardiomyopathy, Lancet, 2, 1462, 10.1016/S0140-6736(73)92730-X Maron, 1976, Asymmetric septal hypertrophy in childhood, Circulation, 53, 9, 10.1161/01.CIR.53.1.9 Elliott, 2001, Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy, Lancet, 357, 420, 10.1016/S0140-6736(00)04005-8 Maron, 2002, Hypertrophic cardiomyopathy, JAMA, 287, 1308, 10.1001/jama.287.10.1308 Cannan, 1995, Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990, Circulation, 92, 2488, 10.1161/01.CIR.92.9.2488 Fay, 1990, Natural history of hypertrophic cardiomyopathy in the elderly, J Am Coll Cardiol, 16, 321, 10.1016/S0735-1097(10)80328-6 Lever, 1989, Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape, Circulation, 79, 580, 10.1161/01.CIR.79.3.580 Lewis, 1989, Elderly patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 13, 36, 10.1016/0735-1097(89)90545-7 Maron, 1999, Clinical course of hypertrophic cardiomyopathy in a regional United States cohort, JAMA, 281, 650, 10.1001/jama.281.7.650 Maron, 1993, Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history, Am J Cardiol, 72, 970, 10.1016/0002-9149(93)91117-Z Klues, 1995, Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy, J Am Coll Cardiol, 26, 1699, 10.1016/0735-1097(95)00390-8 Vital Statistics of the United States 1992, U.S. Department of Health and Human Services, Vol II, Mortality (Part A; Table 9) Le CT. Applied Survival Analysis. New York, NY: Wiley and Sons, 1997:57–61,71–72 McCully, 1996, Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy, Circulation, 94, 467, 10.1161/01.CIR.94.3.467 Faber, 2000, Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, Heart, 83, 326, 10.1136/heart.83.3.326 Maron, 2003, Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy, Am J Cardiol, 91, 40 Niimura, 1998, Mutations in the gene for human cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802 Maron, 2001, Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C mutations, J Am Coll Cardiol, 38, 315, 10.1016/S0735-1097(01)01386-9 Niimura, 2002, Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly, Circulation, 105, 446, 10.1161/hc0402.102990 Obaid, 2001, Apical hypertrophic cardiomyopathy developing at a relatively advanced age, Circulation, 103, 1605, 10.1161/01.CIR.103.11.1605 Maron, 2003, Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, N Engl J Med, 348, 295, 10.1056/NEJMoa021332 Watkins, 2000, Sudden death in hypertrophic cardiomyopathy, N Engl J Med, 342, 422, 10.1056/NEJM200002103420609 Lewis, 1990, Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening, Am J Cardiol, 65, 874, 10.1016/0002-9149(90)91429-A